SOLVE will be part of a project that will investigate micro- and nanoplastics in drinking water. By using our AF4 in combination with Heart-Cutting HC-GC/MS (pyrolysis GC-MS), nanoparticles will be
SOLVE Research and Consultancy (CRO)
SOLVE is providing ex vivo biologics characterization. We are the world leading AF4 contract lab and study therapeutic protein behavior in blood and other tissues, thus investigating the target therapeutic in its intended application. The outcome is an improved cohort selection to maximize the positive impact of the therapeutic while mitigating possible adverse risks for patients.
